£2m Deltex US, German growth:
This article was originally published in Clinica
Executive Summary
UK haemodynamic monitoring company Deltex Medical is looking to expand its sales and marketing operations in the US and Germany with £2m ($4m) of new capital it has secured. The funds, provided in the form of an equity investment-and-loan package, will come from US private equity firm Nexus Medical Partners, and its German affiliate Medicis Capital Partners. Deltex will use the financing to hire additional management and sales staff for its operations in US and Germany. The countries represent the two largest potential markets for the company's CardioQ monitor, according to Chichester, West Essex-based Deltex.